psoriatic arthritis rash legs This stage is usually remedied with over the counter (OTC) medications used to relieve discomfort and pain. Stage 2- At this stage, minor pain is ...
The most common site for arthritis for 1 last update 2020/08/04 in the foot is the base of the big toe. It affects nearly half of patients over the age of 70, but can start in early adulthood. “This can become very painful, limiting the patient’s ability to participate in physical activities,” says UCLA orthopaedic surgeon Joan R. Williams, MD, who specializes in foot and ankle injuries.The most common site for arthritis in the foot is the base of the big toe. It affects nearly half of patients over the age of 70, but can start in early adulthood. “This can become very painful, limiting the patient’s ability to participate in physical activities,” says UCLA orthopaedic surgeon Joan R. Williams, MD, who specializes in foot and ankle injuries.
Patients with so-called great toe arthritis typically present with stiffness and pain, and in some cases with a bump at the site. The condition involves the gradual loss of cartilage around the joint at the base of the big toe, causing swelling and reduced function.
Surgical approaches to treating great toe arthritis typically involve fusing the joint responsible for the pain. While effective in addressing the discomfort, that treatment has a major drawback, Dr. Williams notes. “It’s not ideal for patients who want to retain motion in their great toe, which is necessary for activities like running and jumping.”
Toe-joint replacement procedures also have had problems. When the replacement fails, there tends to be substantial bone loss. Attempting fusion at that point results in poorer outcomes and higher complications than fusion without the replacement, Dr. Williams explains. Nonsurgical treatments include orthotics and anti-inflammatory drugs.
psoriatic arthritis rash legshow to psoriatic arthritis rash legs for For patients who have tried other procedures without success, Dr. Williams now is employing a newer approach to address the condition: a first-of-its-kind synthetic-cartilage implant. The FDA approved the implant in 2016, and Dr. Williams says it has been shown to be effective in relieving pain while retaining motion for patients who suffer from the debilitating condition.
The implant is a polymer device that is designed to have similar properties as joint cartilage. When inserted into joints, it resurfaces the metatarsal head. “This has an excellent survival rate at five years, which is the longest outcome study we have at this point,” Dr. Williams says. “It has been very effective in relieving pain while retaining motion for patients.”
Dr. Williams notes that patients with large cartilage lesions often are not candidates, nor are patients with gout. “Fusion still is an option for patients who can’t benefit from the implant, or for those who aren’t that active and don’t need to retain motion in their toe for their quality of life,” she says. “But having this additional option is a major advance, particularly since we want our older patients to be able to stay active for as long as possible.”